Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 8, 2015, Pages 2241-2248

  Webber, Mark A ^a   Whitehead, Rebekah N ^a   Mount, Manuella ^a   Loman, Nick J ^a   Pallen, Mark J ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Disinfectant; Efflux; MDR

Indexed keywords

BIOCIDE; DNA TOPOISOMERASE (ATP HYDROLYSING); PENTIFYLLINE; QUATERNARY AMMONIUM DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TERTIARY AMINE; TRICLOSAN; DISINFECTANT AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DNA BINDING; EXPRESSION VECTOR; FATTY ACID SYNTHESIS; GENOME; GENOTYPE; LONG TERM EXPOSURE; NONHUMAN; PHENOTYPE; POINT MUTATION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; DRUG EFFECTS; GENETIC SELECTION; GENETICS; HUMAN; MICROBIAL SENSITIVITY TEST; MOLECULAR EVOLUTION; MUTATION;

DISINFECTANTS; DRUG RESISTANCE, BACTERIAL; EVOLUTION, MOLECULAR; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PHENOTYPE; SALMONELLA TYPHIMURIUM; SELECTION, GENETIC;

EID: 84939523101     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv109     Document Type: Article

References (38)

1. Piddock LJ. The crisis of no new antibiotics-what is the way forward? Lancet Infect Dis 2012; 12: 249-53.
2. Woodford N, Livermore DM. Infections caused by Gram-positive bacteria: a review of the global challenge. J Infect 2009; 59 Suppl 1: S4-16.
3. Roca I, Espinal P, Vila-Farres X et al. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol 2012; 3: 148.
4. Tuon FF, Gortz LW, Rocha JL. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. Braz J Infect Dis 2012; 16: 351-6.
5. Walsh TR, Toleman MA. The emergence of pan-resistant Gram-negative pathogens merits a rapid global political response. J Antimicrob Chemother 2012; 67: 1-3.
6. Hawkey PM. Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 2003; 51: 29-35.
7. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001; 32: S9-15.
8. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999; 58 Suppl 2: 11-8.
9. Andersson DI, Hughes D. Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist Updat 2012; 15: 162-72.
10. Hughes D, Andersson DI. Selection of resistance at lethal and nonlethal antibiotic concentrations. Curr Opin Microbiol 2012; 15: 555-60.
11. Marcusson LL, Frimodt-Moller N, Hughes D. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog 2009; 5: e1000541.
12. Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004; 190: 1652-4.
13. Fraise AP. Choosing disinfectants. J Hosp Infect 1999; 43: 255-64.
14. Russell AD. Bacterial spores and chemical sporicidal agents. Clin Microbiol Rev 1990; 3: 99-119.
15. Whitehead RN, Overton TW, Kemp CL et al. Exposure of Salmonella enterica serovar Typhimurium to high level biocide challenge can select multidrug resistant mutants in a single step. PLoS One 2011; 6: e22833.
16. Davin-Regli A, Pages JM. Cross-resistance between biocides and antimicrobials: an emerging question. Rev Sci Tech 2012; 31: 89-104.
17. Gnanadhas DP, Marathe SA, Chakravortty D. Biocides-resistance, cross-resistance mechanisms and assessment. Expert Opin Investig Drugs 2013; 22: 191-206.
18. Karatzas KA, Randall LP, Webber M et al. Phenotypic and proteomic characterization of multiply antibiotic-resistant variants of Salmonella enterica serovar Typhimurium selected following exposure to disinfectants. Appl Environ Microbiol 2008; 74: 1508-16.
19. Karatzas KA, Webber MA, Jorgensen F et al. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. J Antimicrob Chemother 2007; 60: 947-55.
20. Randall LP, Cooles SW, Coldham NG et al. Commonly used farm disinfectants can select for mutant Salmonella enterica serovar Typhimurium with decreased susceptibility to biocides and antibiotics without compromising virulence. J Antimicrob Chemother 2007; 60: 1273-80.
21. Toms LM, Allmyr M, Mueller JF et al. Triclosan in individual human milk samples from Australia. Chemosphere 2011; 85: 1682-6.
22. Savage JH, Johns CB, Hauser R et al. Urinary triclosan levels and recent asthma exacerbations. Ann Allergy Asthma Immunol 2014; 112: 179-81.e2.
23. Pirard C, Sagot C, Deville M et al. Urinary levels of bisphenol A, triclosan and 4-nonylphenol in a general Belgian population. Environ Int 2012; 48: 78-83.
24. Allmyr M, Adolfsson-Erici M, McLachlan MS et al. Triclosan in plasma and milk from Swedish nursing mothers and their exposure via personal care products. Sci Total Environ 2006; 372: 87-93.
25. Wellington EM, Boxall AB, Cross P et al. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis 2013; 13: 155-65.
26. Gaze WH, Zhang L, Abdouslam NA et al. Impacts of anthropogenic activity on the ecology of class 1 integrons and integron-associated genes in the environment. ISME J 2011; 5: 1253-61.
27. Wu X, Ernst F, Conkle JL et al. Comparative uptake and translocation of pharmaceutical and personal care products (PPCPs) by common vegetables. Environ Int 2013; 60: 15-22.
28. Mathews S, Henderson S, Reinhold D. Uptake and accumulation of antimicrobials, triclocarban and triclosan, by food crops in a hydroponic system. Environ Sci Pollut Res Int 2014; 21: 6025-33.
29. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
30. Webber MA, Ricci V, Whitehead R et al. Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance. MBio 2013; 23: e00273-13.
31. Lewis T, Loman NJ, Bingle L et al. High-throughput whole-genome sequencing to dissect the epidemiology of Acinetobacter baumannii isolates from a hospital outbreak. J Hosp Infect 2010; 75: 37-41.
32. Webber MA, Randall LP, Cooles S et al. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008; 62: 83-91.
33. Yoshida H, Bogaki M, Nakamura M et al. Quinolone resistancedetermining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990; 34: 1271-2.
34. Webber MA, Coldham NG, Woodward MJ et al. Proteomic analysis of triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2008; 62: 92-7.
35. Bailey AM, Paulsen IT, Piddock LJ. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine. Antimicrob Agents Chemother 2008; 52: 3604-11.
36. Baucheron S, Imberechts H, Chaslus-Dancla E et al. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb Drug Res 2002; 8: 281-9.
37. Ricci V, Blair JM, Piddock LJ. RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease. J Antimicrob Chemother 2014; 69: 643-50.
38. Jair KW, Martin RG, Rosner JL et al. Purification and regulatory properties of MarA protein, a transcriptional activator of Escherichia coli multiple antibiotic and superoxide resistance promoters. J Bacteriol 1995; 177: 7100-4.